Hemotek Medical Inc. names Charles Ventura CEO

Rohnert Park CA  July 1, 2016 —

Medical device start-up firm Hemotek Medical Incorporated has named Mr. Charles Ventura, formerly of Pfizer, legacy Hospira, as its new Chief Executive Officer. Mr. Ventura will assume the new role immediately, in correlation with the company’s newly announced receipt of a $1.4M Small Business Innovation Research award from the National Institutes of Health  (specialty area, Diabetes, Digestive and Kidney Diseases).  Hemotek Medical Inc. is a small firm dedicated to solving important problems in medicine with creative and low-cost engineering solutions.

Mr. Ventura, a co-founder of Hemotek, has extensive product development experience in the Medical Device industry. He is a seasoned Medical Device leader with successful experience in R&D, Project Management, and Manufacturing Support. He also has start-up experience in business development and investment management. He is the former Manager of Systems Engineering for Pfizer’s (Legacy Hospira) R&D department, in which he successfully created and led the company’s first combination product systems engineering team. In addition, he has gained extensive medical device product development experience at Baxter Healthcare. He is a natural problem solver who excels in seeing the big picture and pulling together large projects with many ambiguous requirements.  Mr. Ventura received his Bachelor’s degree in Bioengineering with a minor in Electrical Engineering from the University of Illinois at Chicago. He went on to earn his M.E. degree in Mechanical and Aerospace Engineering from the Illinois Institute of Technology.  He will be responsible for company strategic vision and overall operations – he will also serve as the head of Quality and Regulatory for all of Hemotek’s new product development projects.

Mr. Ventura succeeds interim CEO Patrick J. Rousche, Ph.D. Dr. Rousche will return to his position as the company’s Chief Scientific Officer (CSO).  The company’s flagship product is the V-Needle, invented by Hemotek Medical Incorporated’s founders, CEO Mr. Ventura, CSO Patrick J. Rousche, Ph.D., Chief Medical Officer (CMO) Peter Tek, D.O. in conjunction with design engineer Richard A. Scribner of Scribner Designs. The V-Needle is designed to protect patients from accidental needle dislodgement during hemodialysis.

Hemotek Medical has laboratory facilities in Rohnert Park, CA.